Lv11
5 积分 2021-04-15 加入
Development of a Scalable Asymmetric Process for the Synthesis of Selective PDE4B Inhibitor Nerandomilast (BI 1015550)
15分钟前
已完结
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)
22分钟前
已完结
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
6小时前
已完结
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability
14天前
已完结
Discovery of Highly Selective Inhibitors of Microtubule-Associated Serine/Threonine Kinase-like (MASTL)
16天前
已完结
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
1个月前
已完结
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3
1个月前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
1个月前
已完结
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
1个月前
已完结
RNA-Binding Small Molecules in Drug Discovery and Delivery: An Overview from Fundamentals
2个月前
已完结
皖公网安备34019202002308
